REVIEW PAPER
Prevalence and factors related to the metabolically obese normalweight (MONW) phenotype: a review
1
Collegium Medicum, Jan Kochanowski University, Kielce, Poland Head of the Collegium: Prof. Marianna Janion MD, PhD
Submission date: 2023-01-04
Final revision date: 2023-02-02
Acceptance date: 2023-02-02
Publication date: 2023-03-31
Corresponding author
Edyta Suliga
Prof. Edyta Suliga Collegium Medicum Jan Kochanowski University Kielce, Poland
Prof. Edyta Suliga Collegium Medicum Jan Kochanowski University Kielce, Poland
Medical Studies 2023;39(1):73-90
KEYWORDS
TOPICS
ABSTRACT
The aim of this review was to assess the prevalence and factors related to the metabolic obesity with normal weight (MONW) phenotype. Studies published in English up to December 2021 in the PubMed, Science Direct and Google Scholar databases were searched. The prevalence of MONW is estimated to range from 1.0% to 28.6%, depending on the age of the study participants and the definition of MONW used in the studies. Difficulties in determining the genetic causes of MONW result primarily from the lack of a uniform definition and from the complexity of the disorder. Each component of MONW may be determined by different genes. A person’s lifestyle, in particular their diet, seems to be a significant factor in the development of MONW. Studies have so far been unable to determine the optimal type and duration of dietary intervention needed to improve the metabolic parameters in individuals with MONW.
REFERENCES (128)
1.
Fan J, Song Y, Chen Y, Hui R, Zhang W. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol 2013; 168: 4761-4768.
2.
Lassale C, Tzoulaki I, Moons KGM, Sweeting M, Boer J, Johnson L, Huerta JM, Agnoli C, Freisling H, Weider- pass E, Wennberg P, van der A D, Arriola L, Benetou V, Boeing H, Bonnet F, Colorado-Yohar SM, Engström G, Eriksen AK, Ferrari P, Grioni S, Johansson M, Kaaks R, Katsoulis M, Katzke V, Key TJ, Matullo G, Melander O, Molina-Portillo E, Moreno-Iribas C, Norberg M, Over- vad K, Panico S, Quirós JR, Saieva C, Skeie G, Steffen A, Stepien M, Tjønneland A, Trichopoulou A, Tumino R, van der Schouw YT, Verschuren WMM, Langenberg C, Di Angelantonio E, Riboli E, Wareham NJ, Danesh J, Butterworth AS. Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur Heart J 2018; 39: 397-406. .
3.
Mirzababaei A, Djafarian K, Mozafari H, Shab-Bidar S. The long-term prognosis of heart diseases for different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies. Endocrine 2019; 63: 439-462.
4.
Schulze MB. Metabolic health in normal-weight and obese individuals. Diabetologia 2019; 62: 558-566.
5.
Meigs JB, Wilson PWF, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D’Agostino RB. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906-2912.
6.
Yaghoubpour K, Tasdighi E, Abdi H, Barzin M, Mahdavi M, Valizadeh M, Azizi F, Hosseinpanah F. Association of obesity phenotypes in adolescents and incidence of early adulthood type 2 diabetes mellitus: Tehran lipid and glucose study. Pediatr Diabetes 2021; 22: 937-945.
7.
Bilic-Curcic I, Cigrovski Berkovic M, Virovic-Jukic L, Mrzljak A. Shifting perspectives – interplay between non-alcoholic fatty liver disease and insulin resistance in lean individuals. World J Hepatol 2021; 13: 80-93.
8.
Liu B, Giffney HE, Arthur RS, Rohan TE, Dannenberg AJ. Cancer risk in normal weight individuals with metabolic obesity: a narrative review. Cancer Prev Res (Phila) 2021; 14: 509-520.
9.
Alizadeh S, Esmaeili H, Alizadeh M, Daneshzad E, Sha- rifi L, Radfar H, Radaei MK. Metabolic phenotypes of obese, overweight, and normal weight individuals and risk of chronic kidney disease: a systematic review and meta-analysis. Arch Endocrinol Metab 2019; 63: 427-437.
10.
Choi KM, Cho HJ, Choi HY, Yang SJ, Yoo HJ, Seo JA, Kim SG, Baik SH, Choi DS, Kim NH. Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans. Clin Endocrinol (Oxf) 2013; 79: 364-370.
11.
Michalsen VL, Wild SH, Kvaløy K, Svartberg J, Melhus M, Broderstad AR. Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study. BMC Cardiovasc Disord 2021; 21: 510.
12.
Ruderman NB, Schneider SH, Berchtold P. The “metabolically-obese,” normal-weight individual. Am J Clin Nutr 1981; 34: 1617-1621.
13.
Phillips CM, Dillon C, Harrington JM, McCarthy VJ, Kearney PM, Fitzgerald AP, Perry IJ. Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS One 2013; 8: e76188.
14.
Chashmniam S, Hashemi Madani N, Nobakht Mothlagh Ghoochani BF, Safari-Alighiarloo N, Khamseh ME. The metabolome profiling of obese and non-obese individuals: metabolically healthy obese and unhealthy non-obese paradox. Iran J Basic Med Sci 2020; 23: 186-194.
15.
Badoud F, Perreault M, Zulyniak MA, Mutch DM. Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals. FASEB J 2015; 29: 748-758.
16.
Klitgaard HB, Kilbak JH, Nozawa EA, Seidel AV, Mag- kos F. Physiological and lifestyle traits of metabolic dysfunction in the absence of obesity. Curr Diab Rep 2020; 20: 17.
17.
Mathew H, Farr OM, Mantzoros CS. Metabolic health and weight: understanding metabolically unhealthy normal weight or metabolically healthy obese patients. Metabolism 2016; 65: 73-80. .
18.
De Lorenzo A, Soldati L, Sarlo F, Calvani M, Di Loren- zo N, Di Renzo L. New obesity classification criteria as a tool for bariatric surgery indication. World J Gastroenterol 2016; 22: 681-703.
19.
Diniz MFHS, Beleigoli AMR, Ribeiro ALP, Vidigal PG, Bensenor IM, Lotufo PA, Duncan BB, Schmidt MI, Barreto SM. Factors associated with metabolically healthy status in obesity, overweight, and normal weight at baseline of ELSA-Brasil. Medicine (Baltimore) 2016; 95: e4010.
20.
Xia L, Dong F, Gong H, Xu G, Wang K, Liu F, Pan L, Zhang L, Yan Y, Gaisano H, He Y, Shan G. Association between indices of body composition and abnormal metabolic phenotype in normal-weight chinese adults. Int J Environ Res Public Health 2017; 14: 391.
21.
Kunzova S, Maugeri A, Medina-Inojosa J, Lopez-Jimenez F, Vinciguerra M, Marques-Vidal P. Determinants of metabolic health across body mass index categories in central europe: a comparison between Swiss and Czech populations. Front Public Health 2020; 8: 108.
22.
Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008; 168: 1617-1624.
23.
Lopez-Garcia E, Guallar-Castillon P, Leon-Muñoz L, Rodriguez-Artalejo F. Prevalence and determinants of metabolically healthy obesity in Spain. Atherosclerosis 2013; 231: 152-157.
24.
Buscemi S, Chiarello P, Buscemi C, Corleo D, Massen- ti MF, Barile AM, Rosafio G, Maniaci V, Settipani V, Cosentino L, Giordano C. Characterization of metabolically healthy obese people and metabolically unhealthy normal-weight people in a general population cohort of the ABCD study. J Diabetes Res 2017; 2017: 9294038. .
25.
Gujral UP, Vittinghoff E, Mongraw-Chaffin M, Vaidya D, Kandula NR, Allison M, Carr J, Liu K, Narayan KMV, Kanaya AM. Cardiometabolic abnormalities among normal-weight persons from five racial/ethnic groups in the United States: a cross-sectional analysis of two cohort studies. Ann Intern Med 2017; 166: 628-636. .
26.
Rotar O, Boyarinova M, Orlov A, Solntsev V, Zhernako- va Y, Shalnova S, Deev A, Konradi A, Baranova E, Chazo- va I, Boytsov S, Shlyakhto E. Metabolically healthy obese and metabolically unhealthy non-obese phenotypes in a Russian population. Eur J Epidemiol 2017; 32: 251-254.
27.
Oliveros E, Somers VK, Sochor O, Goel K, Lopez-Jime- nez F. The concept of normal weight obesity. Prog Cardiovasc Dis 2014; 56: 426-433. .
28.
Hajian-Tilaki K, Heidari B. Metabolically healthy obese and unhealthy normal weight in Iranian adult population: prevalence and the associated factors. Diabetes Metab Syndr 2018; 12: 129-134. .
29.
Rahmanian K, Shojaei M, Sotoodeh Jahromi A. Prevalence and clinical characteristics of metabolically unhealthy obesity in an Iranian adult population. Diabetes Metab Syndr Obes 2019; 12: 1387-1395.
30.
Izumida T, Nakamura Y, Ishikawa S. Impact of body mass index and metabolically unhealthy status on mortality in the Japanese general population: the JMS cohort study. PLoS One 2019; 14: e0224802.
31.
Samouda H, Ruiz-Castell M, Karimi M, Bocquet V, Kuemmerle A, Chioti A, Dadoun F, Stranges S. Metabolically healthy and unhealthy weight statuses, health issues and related costs: findings from the 2013-2015 European Health Examination Survey in Luxembourg. Diabetes Metab 2019; 45: 140-151. .
32.
Mirmiran P, Moslehi N, Hosseinpanah F, Sarbazi N, Azizi F. Dietary determinants of unhealthy metabolic phenotype in normal weight and overweight/obese adults: results of a prospective study. Int J Food Sci Nutr 2020; 71: 891-901.
33.
Zheng Q, Lin W, Liu C, Zhou Y, Chen T, Zhang L, Zhang X, Yu S, Wu Q, Jin Z, Zhu Y. Prevalence and epidemiological determinants of metabolically obese but normal-weight in Chinese population. BMC Public Health 2020; 20: 487. .
34.
Fan L, Qiu J, Zhao Y, in T, Li X, Wang Q, Jing J, Zhang J, Wang F, Liu X, Liu L, Zhao Y, Zhang Y. The association between body composition and metabolically unhealthy profile of adults with normal weight in Northwest China. PLoS One 2021; 16: e0248782.
35.
Wang WQ, Wei B, Song YP, Guo H, Zhang XH, Wang XP, Yan YZ, Ma JL, Wang K, Keerman M, Zhang JY, Guo SX, He J. Metabolically healthy obesity and unhealthy normal weight rural adults in Xinjiang: prevalence and the associated factors. BMC Public Health 2021; 21: 1940.
36.
Robson E, Norris T, Costa S, Kivimäki M, Hamer M, Johnson W. Contribution of 20-year body mass index and waist circumference history to poor cardiometabolic health in overweight/obese and normal weight adults: a cohort study. Nutr Metab Cardiovasc Dis. 2021; 31: 2851-2859.
37.
Lee K. Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. Asia Pac J Clin Nutr 2009; 18: 280-284. .
38.
Pajunen P, Kotronen A, Korpi-Hyövälti E, Keinänen-Kiukaanniemi S, Oksa H, Niskanen L, Saaristo T, Saltevo JT, Sundvall J, Vanhala M, Uusitupa M, Peltonen M. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Public Health 2011; 11: 754. .
39.
Bradshaw PT, Monda KL, Stevens J. Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the Atherosclerosis Risk in Communities Study. Obesity (Silver Spring) 2013; 21: 203-209.
40.
Eckel N, Mühlenbruch K, Meidtner K, Boeing H, Ste- fan N, Schulze MB. Characterization of metabolically unhealthy normal-weight individuals: risk factors and their associations with type 2 diabetes. Metabolism 2015; 64: 862-871.
41.
Suliga E, Kozieł D, Głuszek S. Prevalence of metabolic syndrome in normal weight individuals. Ann Agric Environ Med 2016; 23: 631-635.
42.
Goday A, Calvo E, Vázquez LA, Caveda E, Margallo T, Catalina-Romero C, Reviriego J. Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/non-obese metabolic phenotypes in a working population: results from the Icaria study. BMC Public Health 2016; 16: 248. .
43.
Zhang Y, Fu J, Yang S, Yang M, Liu A, Wang L, Cao S, Sun X, Wang F, Liu D. Prevalence of metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) in Chinese Beijing urban subjects. Biosci Trends 2017; 11: 418-426. .
44.
Fernández-Verdejo R, Moya-Osorio JL, Fuentes-López E, Galgani JE. Metabolic health and its association with lifestyle habits according to nutritional status in Chile: a cross-sectional study from the National Health Survey 2016-2017. PLoS One 2020; 15: e0236451.
45.
Ojwang AA, Smuts CM, Zec M, Wentzel-Viljoen E, Kruger IM, Kruger HS. Comparison of dietary and plasma phospholipid fatty acids between normal weight and overweight black South Africans according to metabolic health: the PURE study. Prostaglandins Leukot Essent Fatty Acids 2020; 158: 102039.
46.
Zhu L, Yang WJ, Spence CB, Bhimla A, Ma GX. Lean yet unhealthy: asian american adults had higher risks for metabolic syndrome than non-hispanic white adults with the same body mass index: evidence from NHANES 2011-2016. Healthcare (Basel) 2021; 9: 1518. .
47.
Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. a consensus statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
48.
Zoghi G, Shahbazi R, Mahmoodi M, Nejatizadeh A, Kheirandish M. Prevalence of metabolically unhealthy obesity, overweight, and normal weight and the associated risk factors in a southern coastal region, Iran (the PERSIAN cohort study): a cross-sectional study. BMC Public Health 2021; 21: 2011.
49.
Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses’ Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol 2018; 6: 714-724.
50.
Kim JA, Kim DH, Kim SM, Park YG, Kim NH, Baik SH, Choi KM, Han K, Yoo HJ. Impact of the dynamic change of metabolic health status on the incident type 2 diabetes: a nationwide population-based cohort study. Endocrinol Metab (Seoul) 2019; 34: 406-414.
51.
Elías-López D, Vargas-Vázquez A, Mehta R, Cruz Bautista I, Del Razo Olvera F, Gómez-Velasco D, Almeda Valdes P, Aguilar-Salinas CA; Metabolic Syndrome Study Group. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study. BMC Endocr Disord 2021; 21: 85. .
52.
Kabat GC, Wu WY, Bea JW, Chen C, Qi L, Stefanick ML, Chlebowski RT, Lane DS, Wactawski-Wende J, Wassertheil-Smoller S, Rohan TE. Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women. Int J Obes (Lond) 2017; 41: 170-177. .
53.
Gutiérrez-Repiso C, Soriguer F, Rojo-Martínez G, García-Fuentes E, Valdés S, Goday A, Calle-Pascual A, López-Alba A, Castell C, Menéndez E, Bordiú E, Delgado E, Orte- ga E, Pascual-Manich G, Urrutia I, Mora-Peces I, Vendrell J, Vázquez JA, Franch J, Girbés J, Castaño L, Serrano- Ríos M, Martínez-Larrad MT, Catalá M, Carmena Ra, Gomis R, Casamitjana R, Gaztambide S. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study. Nutr Metab Cardiovasc Dis 2014; 24: 947-55.
54.
Thomas EL, Parkinson JR, Frost GS, Goldstone AP, Doré CJ, McCarthy JP, Collins AL, Fitzpatrick JA, Durighel G, Taylor-Robinson SD, Bell JD. The missing risk: MRI and MRS phenotyping of abdominal adiposity and ectopic fat. Obesity (Silver Spring) 2012; 20: 76-87. .
55.
Du T, Yu X, Zhang J, Sun X. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype. Acta Diabetol 2015; 52: 855-863. .
56.
Lu YC, Lin YC, Yen AM, Chan WP. Dual-energy X-ray absorptiometry-assessed adipose tissues in metabolically unhealthy normal weight Asians. Sci Rep 2019; 9: 17698.
57.
Cota BC, Ribeiro SAV, Priore SE, Juvanhol LL, de Faria ER, de Faria FR, Pereira PF. Anthropometric and body composition parameters in adolescents with the metabolically obese normal-weight phenotype. Br J Nutr 2021; 127: 1458-1466.
58.
Ramirez-Velez R, Correa-Bautista JE, Lobelo F, Izquier- do M, Alonso-Martínez A, Rodríguez-Rodríguez F, Cristi-Montero C. High muscular fitness has a powerful protective cardiometabolic effect in adults: influence of weight status. BMC Public Health 2016; 16: 1012.
59.
Tranæs K, Ding C, Chooi YC, Chan Z, Choo J, Leow MK, Magkos F. Dissociation between insulin resistance and abnormalities in lipoprotein particle concentrations and sizes in normal-weight Chinese adults. Front Nutr 2021; 8: 651199. .
60.
Ding C, Chan Z, Chooi YC, Choo J, Sadananthan SA, Chang A, Sasikala S, Michael N, Velan SS, Magkos F. Regulation of glucose metabolism in nondiabetic, metabolically obese normal-weight Asians. Am J Physiol Endocrinol Metab 2018; 314: E494-E502.
61.
Kim JW, Kim DH, Roh YK, Ju SY, Nam HY, Nam GE, Kim DW, Lee SH, Lee CW, Han K, Park YG. Serum ferritin levels are positively associated with metabolically obese normal weight: a nationwide population-based study. Medicine (Baltimore) 2015; 94: e2335. .
62.
Gómez-Zorita S, Queralt M, Vicente MA, González M, Portillo MP. Metabolically healthy obesity and metabolically obese normal weight: a review. J Physiol Biochem 2021; 77: 175-189. .
63.
Hyun YJ, Koh SJ, Chae JS, Kim JY, Kim OY, Lim HH, Jang Y, Park S, Ordovas JM, Lee JH. Atherogenecity of LDL and unfavorable adipokine profile in metabolically obese, normal-weight woman. Obesity (Silver Spring) 2008; 16: 784-789.
64.
Liu L, Liu S, Song Q, Luo D, Su Y, Qi X, Wang Q, Ning J, Lv Y, Guan Q. Association of metabolic obesity phenotypes and total testosterone in Chinese male population. Diabetes Metab Syndr Obes 2021; 14: 399-408.
65.
De Lorenzo A, Del Gobbo V, Premrov MG, Bigioni M, Galvano F, Di Renzo L. Normal-weight obese syndrome: early inflammation? Am J Clin Nutr 2007; 85: 40-45. .
66.
Kim M, Paik JK, Kang R, Kim SY, Lee SH, Lee JH. Increased oxidative stress in normal-weight postmenopausal women with metabolic syndrome compared with metabolically healthy overweight/obese individuals. Metabolism 2013; 62: 554-560.
67.
Molero-Conejo E, Morales LM, Fernández V, Raleigh X, Gómez ME, Semprún-Fereira M, Campos G, Ryder E. Lean adolescents with increased risk for metabolic syndrome. Arch Latinoam Nutr 2003; 53: 39-46.
68.
Guerrero-Romero F, Aradillas-Garcia C, Simental-Mendia LE, Torres-Rodríguez ML, Mendoza Ede L, Rosales-Cervantes J, Rodríguez-Ramírez G, Rodríguez-Moran M. Biochemical characteristics and risk factors for insulin resistance at different levels of obesity. Pediatrics 2013; 131: e1211-1217.
69.
Simental-Mendía LE, Hernández-Ronquillo G, Gómez-Díaz R, Rodríguez-Morán M, Guerrero-Romero F. The triglycerides and glucose index is associated with cardiovascular risk factors in normal-weight children and adolescents. Pediatr Res 2017; 82: 920-925.
70.
Li G, Li Y, Han L, Wang D, Zhang Q, Xiao X, Qi L, Willi SM, Li M, Mi J, Gao S. Interaction between early environment and genetic predisposition instigates the metabolically obese, normal weight phenotype in children: findings from the BCAMS study. Eur J Endocrinol 2020; 182: 393-403.
71.
Viitasalo A, Pitkänen N, Pahkala K, Lehtimäki T, Viika- ri JSA, Raitakari O, Kilpeläinen TO. Increase in adiposity from childhood to adulthood predicts a metabolically obese phenotype in normal-weight adults. Int J Obes (Lond) 2020; 44: 848-851.
72.
Van Hulst A, Ybarra M, Mathieu ME, Benedetti A, Para- dis G, Henderson M. Determinants of new onset cardiometabolic risk among normal weight children. Int J Obes (Lond) 2020; 44: 781-789.
73.
Huang LO, Loos RJF, Kilpeläinen TO. Evidence of genetic predisposition for metabolically healthy obesity and metabolically obese normal weight. Physiol Genomics 2018; 50: 169-178.
74.
Yaghootkar H, Scott RA, White CC, Zhang W, Speliotes E, Munroe PB, Ehret GB, Bis JC, Fox CS, Walker M, Borecki IB, Knowles JW, Yerges-Armstrong L, Ohlsson C, Perry JRB, Chambers JC, Kooner JS, Franceschini N, Langenberg C, Hivert MF, Dastani Z, Richards JB, Semple RK, Frayling TM. Genetic evidence for a normal-weight “metabolically obese” phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes. Diabetes 2014; 63: 4369-4377. .
75.
Park JM, Park DH, Song Y, Kim JO, Choi JE, Kwon YJ, Kim SJ, Lee JW, Hong KW. Understanding the genetic architecture of the metabolically unhealthy normal weight and metabolically healthy obese phenotypes in a Korean population. Sci Rep 2021; 11: 2279. .
76.
Zhu X, Hu J, Yang M, Guo H, Ji D, Li Y, Wang W, Xue C, Wang N, Zhang X, Hu X, Liu Y, Sun K, Sun Z, Wang B. A genetic analysis identifies haplotype at adiponectin locus: association with the metabolic health and obesity phenotypes. Gene 2021; 784: 145593.
77.
Hovsepian S, Javanmard SH, Mansourian M, Hashemipour M, Tajadini M, Kelishadi R. Lipid regulatory genes polymorphism in children with and without obesity and cardiometabolic risk factors: the CASPIAN-III study. J Res Med Sci 2018; 23: 11. .
78.
Abolnezhadian F, Hosseini SA, Alipour M, Zakerkish M, Cheraghian B, Ghandil P, Cheraghpour M. Association metabolic obesity phenotypes with cardiometabolic index, atherogenic index of plasma and novel anthropometric indices: a link of FTO-rs9939609 polymorphism. Vasc Health Risk Manag 2020; 16: 249-256.
79.
Winkler TW, Günther F, Höllerer S, Zimmermann M, Loos RJ, Kutalik Z, Heid IM. A joint view on genetic variants for adiposity differentiates subtypes with distinct metabolic implications. Nat Commun 2018; 9: 1946.
80.
Sulc J, Winkler TW, Heid IM, Kutalik Z. Heterogeneity in obesity: genetic basis and metabolic consequences. Curr Diab Rep 2020; 20: 1. .
81.
Huang LO, Rauch A, Mazzaferro E, Preuss M, Carobbio S, Bayrak CS, Chami N, Wang Z, Schick UM, Yang N, Itan Y, Vidal-Puig A, den Hoed M, Mandrup S, Kilpeläinen TO, Loos RJF. Genome-wide discovery of genetic loci that uncouple excess adiposity from its comorbidities. Nat Metab 2021; 3: 228-243. .
82.
Lutsey PL, Steffen LM, Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation 2008; 117: 754-761.
83.
Fabiani R, Naldini G, Chiavarini M. dietary patterns and metabolic syndrome in adult subjects: a systematic review and meta-analysis. Nutrients 2019; 11: 2056.
84.
Suliga E, Kozieł D, Cieśla E, Głuszek S. Association between dietary patterns and metabolic syndrome in individuals with normal weight: a cross-sectional study. Nutr J 2015; 14: 55.
85.
Osadnik K, Osadnik T, Lonnie M, Lejawa M, Reguła R, Fronczek M, Gawlita M, Wądołowska L, Gąsior M, Pawlas N. Metabolically healthy obese and metabolic syndrome of the lean: the importance of diet quality. Analysis of MAGNETIC cohort. Nutr J 2020; 19: 19.
86.
Bell LK, Edwards S, Grieger JA. The relationship between dietary patterns and metabolic health in a representative sample of adult Australians. Nutrients 2015; 7: 6491-6505.
87.
Pereira DL, Juvanhol LL, Silva DC, Longo GZ. Dietary patterns and metabolic phenotypes in Brazilian adults: a population-based cross-sectional study. Public Health Nutr 2019; 22: 3377-3383.
88.
Park YM, Fung TT, Steck SE, Zhang J, Hazlett LJ, Han K, Lee SH, Merchant AT. Diet quality and mortality risk in metabolically obese normal-weight adults. Mayo Clin Proc 2016; 91: 1372-1383.
89.
Park YM, Steck SE, Fung TT, Zhang J, Hazlett LJ, Han K, Lee SH, Kwon HS, Merchant AT. Mediterranean diet, dietary approaches to stop hypertension (DASH) style diet, and metabolic health in U.S. adults. Clin Nutr 2017; 36: 1301-1309.
90.
Hashemipour S, Esmailzadehha N, Mohammadzadeh M, Ziaee A. Association of meat and dairy consumption with normal weight metabolic obesity in men: the Qazvin Metabolic Diseases Study. Eat Weight Disord 2016; 21: 419-425.
91.
Choi J, Se-Young O, Lee D, Tak S, Hong M, Park SM, Cho B, Park M. Characteristics of diet patterns in metabolically obese, normal weight adults (Korean National Health and Nutrition Examination Survey III, 2005). Nutr Metab Cardiovasc Dis 2012; 22: 567-574.
92.
Nier A, Brandt A, Baumann A, Conzelmann IB, Özel Y, Bergheim I. Metabolic abnormalities in normal weight children are associated with increased visceral fat accumulation, elevated plasma endotoxin levels and a higher monosaccharide intake. Nutrients 2019; 11: 652.
93.
Vasbinder A, Tinker LF, Neuhouser ML, Pettinger M, Hale L, Di C, Zaslavsky O, Hayman LL, Lin X, Eaton C, Wang D, Scherman A, Stefanick ML, Barrington WE, Reding KW. Risk of metabolic syndrome and metabolic phenotypes in relation to biomarker-calibrated estimates of energy and protein intakes: an investigation from the Women’s Health Initiative. Am J Clin Nutr 2021; 113: 706-715.
94.
Moslehi NM, Golzarand F, Hosseinpanah P, Mirmi- ran P, Azizi F. Dietary intakes of flavonoids and carotenoids and the risk of developing an unhealthy metabolic phenotype. Food Function 2020; 11: 3451-3458.
95.
Wang X, Chang X, Zhu Y, Wang H, Sun K. Metabolically obese individuals of normal weight have a high risk of 25-hydroxyvitamin D deficiency. Am J Med Sci 2016; 352: 360-367.
96.
Esmaili H, Heshmat R, Ejtahed HS, Rastad H, Mot- lagh ME, Asayesh H, Jafarnejad M, Seif E, Qorbani M, Kelishadi R. Association of serum 25-hydroxyvitamin D level with metabolic phenotypes of obesity in children and adolescents: the CASPIAN-V Study. Front Endocrinol (Lausanne) 2020; 11: 310.
97.
Guerrero-Romero F, Rodriguez-Moran M. Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects. Eur J Intern Med 2013; 24: 639-643.
98.
Rodríguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial. Arch Med Res 2014; 45: 388-393.
99.
Osadnik K, Osadnik T, Delijewski M, Lejawa M, Fronczek M, Reguła R, Gąsior M, Pawlas N. Calcium and phosphate levels are among other factors associated with metabolic syndrome in patients with normal weight. Diabetes Metab Syndr Obes 2020; 13: 1281-1288.
100.
Conus F, Allison DB, Rabasa-Lhoret R, St-Onge M, St-Pierre DH, Tremblay-Lebeau A, Poehlman ET. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 2004; 89: 5013-5020.
101.
Most J, Tosti V, Redman LM, Fontana L. Calorie restriction in humans: an update. Ageing Res Rev 2017; 39: 36-45.
102.
Hoddy KK, Marlatt KL, Çetinkaya H, Ravussin E. Intermittent fasting and metabolic health: from religious fast to time-restricted feeding. Obesity (Silver Spring) 2020; 28 (Suppl 1): S29-S37.
103.
Lee K. Estimation of weight status and weight-loss efforts in Korean adults with non-obesity considering metabolic syndrome. Eat Weight Disord 2019; 24: 135-142.
104.
Chooi YC, Ding C, Chan Z, Choo J, Sadananthan SA, Michael N, Lee Y, Velan SS, Magkos F. Moderate weight loss improves body composition and metabolic function in metabolically unhealthy lean subjects. Obesity (Silver Spring) 2018; 26: 1000-1007.
105.
Most J, Gilmore LA, Smith SR, Han H, Ravussin E, Redman LM. Significant improvement in cardiometabolic health in healthy nonobese individuals during caloric restriction-induced weight loss and weight loss maintenance. Am J Physiol Endocrinol Metab 2018; 314: E396-E405.
106.
Templeman I, Gonzalez JT, Thompson D, Betts JA. The role of intermittent fasting and meal timing in weight management and metabolic health. Proc Nutr Soc 2020; 79: 76-87.
107.
de Cabo R, Mattson MP. Effects of intermittent fasting on health, aging, and disease. N Engl J Med 2019; 381: 2541-2551.
108.
Crupi AN, Haase J, Brandhorst S, Longo VD. Periodic and intermittent fasting in diabetes and cardiovascular disease. Curr Diab Rep 2020; 20: 83.
109.
Anton SD, Moehl K, Donahoo WT, Marosi K, Lee SA, Mainous AG 3rd, Leeuwenburgh C, Mattson MP. Flipping the metabolic switch: understanding and applying the health benefits of fasting. Obesity 2018; 26: 254-268.
110.
Harvie MN, Howell T. Could intermittent energy restriction and intermittent fasting reduce rates of cancer in obese, overweight, and normal-weight subjects? A summary of evidence. Adv Nutr 2016; 7: 690-705. .
111.
Heilbronn LK, Smith SR, Martin CK, Anton SD, Ravus- sin E. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr 2005; 81: 69-73.
112.
Varady KA, Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Haus JM, Hoddy KK, Calvo Y. Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial. Nutr J 2013; 12: 146.
113.
Wegman MP, Guo M, Bennion DM, Shankar MN, Chrzanowski SM, Goldberg LA, Xu J, Williams TA, Lu X, Hsu SI. Practicality of intermittent fasting in humans and its effect on oxidative stress and genes related to aging and metabolism. Rejuvenation Res 2015; 18: 162-172.
114.
Stekovic S, Hofer SJ, Tripolt N, Aon MA, Royer P, Pein L, Stadler JT, Pendl T, Prietl B, Url J, Schroeder S, Tadic J, Eisenberg T, Magnes C, Stumpe M, Zuegner E, Bor- dag N, Riedl R, Schmidt A, Kolesnik E, Verheyen N, Springer A, Madl T, Sinner F, de Cabo R, Kroemer G, Obermayer-Pietsch B, Dengjel J, Sourij H, Pieber TR, Madeo F. Alternate day fasting improves physiological and molecular markers of aging in healthy, non-obese humans. Cell Metab 2019; 30: 462-476.
115.
Chow LS, Manoogian ENC, Alvear A, Fleischer JG, Thor H, Dietsche K, Wang Q, Hodges JS, Esch N, Malaeb S, Harindhanavudhi T, Nair KS, Panda S, Mashek DG. Time-restricted eating effects on body composition and metabolic measures in humans who are overweight: a feasibility study. Obesity (Silver Spring) 2020; 28: 860-869.
116.
Wei M, Brandhorst S, Shelehchi M, Mirzaei H, Cheng CW, Budniak J, Groshen S, Mack WJ, Guen E, Di Biase S, Cohen P, Morgan TE, Dorff T, Hong K, Michalsen A, Laviano A, Longo VD. Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease. Sci Transl Med 2017; 9: eaai8700.
117.
Bak AM, Møller AB, Vendelbo MH, Nielsen TS, Viggers R, Rungby J, Pedersen SB, Jørgensen JO, Jessen N, Møller N. Differential regulation of lipid and protein metabolism in obese vs. lean subjects before and after a 72-h fast. Am J Physiol Endocrinol Metab 2016; 311: E224-E235.
118.
Martinez-Gomez D, Ortega FB, Hamer M, Lopez-Gar- cia E, Struijk E, Sadarangani KP, Lavie CJ, Rodríguez-Artalejo F. Physical activity and risk of metabolic phenotypes of obesity: a prospective Taiwanese cohort study in more than 200,000 adults. Mayo Clin Proc 2019; 94: 2209-2219.
119.
Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in metabolically obese but normalweight young women. Diabetes 1999; 48: 2210-2214.
120.
Suliga E, Cieśla E, Rębak D, Kozieł D, Głuszek S. Relationship between sitting time, physical activity, and metabolic syndrome among adults depending on body mass index (BMI). Med Sci Monit 2018; 24: 7633-7645.
121.
Kuzik N, Carson V, Andersen LB, Sardinha LB, Grønt- ved A, Hansen BH, Ekelund U. Physical activity and sedentary time associations with metabolic health across weight statuses in children and adolescents. Obesity (Silver Spring) 2017; 25: 1762-1769.
122.
Ryu JY, Lee JS, Hong HC, Choi HY, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. Association between body size phenotype and sleep duration: Korean National Health and Nutrition Examination Survey V (KNHANES V). Metabolism 2015; 64: 460-466.
123.
Lim HH. Sleep duration independently influences metabolic body size phenotype in children and adolescents: a population-based study. Sleep Med 2018; 42: 47-52.
124.
Copinschi G, Leproult R, Spiegel K. The important role of sleep in metabolism. Front Horm Res 2014; 42: 59-72.
125.
Krittanawong C, Tunhasiriwet A, Wang Z, Zhang H, Farrell AM, Chirapongsathorn S, Sun T, Kitai T, Argulian E. Association between short and long sleep durations and cardiovascular outcomes: a systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care 2019; 8: 762-770.
126.
Hardy DS, Racette SB, Garvin JT, Gebrekristos HT, Mersha TB. Ancestry specific associations of a genetic risk score, dietary patterns and metabolic syndrome: a longitudinal ARIC study. BMC Med Genomics 2021; 14: 118. .
127.
Rubin R. What’s the best way to treat normal-weight people with metabolic abnormalities? JAMA 2018; 320: 223-225.
128.
Williamson E, Moore DR. A muscle-centric perspective on intermittent fasting: a suboptimal dietary strategy for supporting muscle protein remodeling and muscle mass? Front Nutr 2021; 8: 640621.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
